DS
ANIP icon

DRW Securities’s ANI Pharmaceuticals ANIP Stock Holding History

DRW Securities’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-4,600
Closed -$296K – 188
2017
Q4 		$296K Buy
+4,600
New +$286K 0.03% 325

Other funds holding ANIP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DRW Securities's ANIP Position: Q2 2026 in Review

DRW Securities opened a new position in ANI Pharmaceuticals (ANIP) in Q2 2026: 2,831 shares worth $234K. The stake represents 0.01% of the portfolio and ranks #727 among its holdings.

307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

  • DRW Securities held 2,831 shares of ANI Pharmaceuticals worth $234K as of Q2 2026.
  • ANI Pharmaceuticals was a new DRW Securities position in Q2 2026.
  • ANI Pharmaceuticals made up 0.01% of DRW Securities's portfolio in Q2 2026, its #727 holding.
  • 307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.